Tuesday, December 11, 2012

• Galena Biopharma: Recent Developments Paint A Picture Of The Year Aheadat Seeking Alpha (Tue, Dec 11)

Monday, December 10, 2012

• Galena On Track to Advance NeuVaxZacks (Mon, Dec 10)
• 2 Biotech Firms With Significant Upside In The Wake Of Recent Developmentsat Seeking Alpha (Mon, Dec 10)

Sunday, December 9, 2012

• Galena Presents Data, Sarepta Updates Study: Healthcare Business Wrapat Wall St. Cheat Sheet (Sun, Dec 9)

Friday, December 7, 2012

• Galena falls on latest data for cancer treatmentAP (Fri, Dec 7)
• Biotech Stock Mailbag: YM Bio, Infinity, Delcath and Galenaat TheStreet (Fri, Dec 7)

Thursday, December 6, 2012

• The Top-Performing Biotechs in 2012 and 1 to Watch in 2013at Motley Fool (Thu, Dec 6)

Wednesday, December 5, 2012

• Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Fieldat Seeking Alpha (Wed, Dec 5)

Tuesday, December 4, 2012

• Galena Reaches Deal with Teva, IRIDEX Wins FDA & CE Approval: Healthcare Business Recapat Wall St. Cheat Sheet (Tue, Dec 4)
• GALENA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other EventsEDGAR Online (Tue, Dec 4)
• As Galena Teams Up With Teva, Shares Now Possess Some Very Nice Upside Potentialat Seeking Alpha (Tue, Dec 4)
• Galena says Teva will co-develop NeuVax in IsraelAP (Tue, Dec 4)

Friday, November 30, 2012

• Wall Street Loves Galena Biopharma. Should You?at Motley Fool (Fri, Nov 30)

Wednesday, November 28, 2012

• Galena Biopharma initiated with a Buy at Aegisat theflyonthewall.com (Wed, Nov 28)
• Acadia Pharmaceuticals And Galena Biopharma: What A Difference A Trial Design Can Makeat Seeking Alpha (Wed, Nov 28)

Tuesday, November 27, 2012

• 10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlookat TheStreet (Tue, Nov 27)

Monday, November 26, 2012

• Novel Immunotherapy And Delivery Systems Targeting Cancer May Target Gains For Investorsat Seeking Alpha (Mon, Nov 26)

Tuesday, November 20, 2012

• Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate IncreasesMarketwired (Tue, Nov 20)
• A Fact Based Analysis Of Galena's NeuVaxat Seeking Alpha (Tue, Nov 20)

Tuesday, November 13, 2012

• GALENA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExEDGAR Online (Tue, Nov 13)

Monday, November 12, 2012

• Galena Biopharma: Catalysts Have Led Its Stock Higherat Seeking Alpha (Mon, Nov 12)

Sunday, November 11, 2012

• 3 Acquisitions In Biotechnology That Could Occur In The Next Yearat Seeking Alpha (Sun, Nov 11)

Tuesday, November 6, 2012

• 2 Biotech Stocks I'm Considering In The Near-Termat Seeking Alpha (Tue, Nov 6)

Monday, November 5, 2012

• Banco Santander Initiated at Outperform and 4 Initiated Shares Not to Ignoreat Wall St. Cheat Sheet (Mon, Nov 5)
• Investments In The Fight Against Cancer: The Analysts' Choicesat Seeking Alpha (Mon, Nov 5)

Add GALE News to My Yahoo!